Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacing in patients with atrial fibrillation refractory to antiarrhythmic drugs or catheter ablation

[1] Allessie M(2002)Electrical, contractile and structural remodeling during atrial fibrillation Cardiovascular Research 54 230-246

[2] Ausma J(2014)Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF Study JAMA 311 498-506

[3] Schotten U(2008)Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control Heart Rhythm 5 839-845

[4] Marrouche N(2004)Catheter ablation for atrial fibrillation in congestive heart failure New England Journal of Medicine 351 2373-2383

[5] Wilber D(2013)Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation Heart Rhythm 10 1334-1339

[6] Hindricks G(2008)Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms Journal of the American College of Cardiology 52 1834-1843

[7] Jais P(2010)Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up Journal of the American College of Cardiology 55 1788-1795

[8] Akoum N(2004)Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation American Journal of Cardiology 93 569-575

[9] Marchlinski F(1998)Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial Journal of Interventional Cardiac Electrophysiology 2 139-144

[10] Avitall B(2002)Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy Journal of the American College of Cardiology 46 1140-1150

[1] Allessie M(2002)Electrical, contractile and structural remodeling during atrial fibrillation Cardiovascular Research 54 230-246

[2] Ausma J(2014)Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF Study JAMA 311 498-506

[3] Schotten U(2008)Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control Heart Rhythm 5 839-845

[4] Marrouche N(2004)Catheter ablation for atrial fibrillation in congestive heart failure New England Journal of Medicine 351 2373-2383

[5] Wilber D(2013)Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation Heart Rhythm 10 1334-1339

[6] Hindricks G(2008)Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms Journal of the American College of Cardiology 52 1834-1843

[7] Jais P(2010)Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up Journal of the American College of Cardiology 55 1788-1795

[8] Akoum N(2004)Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation American Journal of Cardiology 93 569-575

[9] Marchlinski F(1998)Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial Journal of Interventional Cardiac Electrophysiology 2 139-144

[10] Avitall B(2002)Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy Journal of the American College of Cardiology 46 1140-1150